LifeArc licenses lead stage molecules to Daiichi Sankyo
The deal to license an ion channel drug discovery programme marks the successful outcome of a collaboration between LifeArc, Oxford University’s NDCN and Daiichi Sankyo.
27 March 2019
Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance
24 February 2017
MRC Technology joins project UTILE to enable medical breakthroughs from European funded research